Sang-Moo Kang

30PUBLICATIONS
35CO-AUTHORS
Infant and child healthInnate immunityNanotoxicology, health and safetyMedical devicesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 06, 2026
Intranasal Delivery of an RSV A2-Derived Pre-F VLP Vaccine Induces Robust Mucosal and Systemic Immunity Against RSV B Strain Without Enhanced Disease.

|Mar 27, 2026
Type I interferon signaling is required for resistance to primary influenza virus infection and vaccine-induced long-term immunity.

Ki-Hye Kim, Hye Suk Hwang, Surya Sekhar Pal

|Nov 12, 2025
Virus-like Particle Vaccines Containing RSV Fusion Protein Cleavage Mutations Are Immunogenic and Protective in Cotton Rats With a Prime Dose.

Hye Suk Hwang, Young-Man Kwon, Ki-Hye Kim

|Apr 23, 2025
Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination.

Chau Thuy Tien Le, Ki-Hye Kim, Jannatul Ruhan Raha

|Apr 20, 2025
Gut microbiota modulate immune responses to orally and parenterally administered rotavirus in mice.

Zhenda Shi, Sung-Sil Moon, Jun Zou

|Jul 10, 2024
Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines.

Chunhong Dong, Wandi Zhu, Lai Wei

Pageof 5

Frequent Collaborators

7 joint publications

Baozhong Wang

7 joint publications

Noopur Bhatnagar

5 joint publications

Chong-Hyun Shin

3 joint publications

Ipshita Menon